Healthy Extracts Inc. (HYEX) Stock Price & Analysis
Healthy Extracts Inc. (HYEX) rose 0.00% to USD 0.91 as of July 25, 2026 at 16:26 UTC, according to Nexqual real-time market data.
HYEX last closed at USD 0.91; the session ranged USD 0.82–1.58 on volume of 222 shares. Market capitalization is $13.46M, with a 52-week range of USD 0.81–3.35 (OQB). Source: Nexqual, July 25, 2026 at 16:26 UTC.
Key Statistics (as of July 25, 2026 at 16:26 UTC)
| Price | USD 0.91 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.91 |
| Open | USD 1.58 |
| Day Range | USD 0.82 – 1.58 |
| 52-Week Range | USD 0.81 – 3.35 |
| Volume | 222 shares |
| Market Cap | $13.46M |
| Exchange | OQB |
Technical Analysis (HYEX)
Nexqual's technical model rates HYEX "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 16:26 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 29.83 (oversold) |
| vs SMA50 | Below (USD 1.89) |
| MACD | -0.31 (negative) |
Analyst Ratings (HYEX)
Wall Street analysts rate HYEX "None", per Nexqual as of July 25, 2026 at 16:26 UTC.
| Consensus Rating | None |
|---|
Earnings (HYEX)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-09-30 | USD -0.06 vs est -0.1 ▲ beat |
Source: Nexqual, July 25, 2026 at 16:26 UTC.
Financials & Fundamentals (HYEX)
| Total Revenue | $5.19M |
|---|---|
| Revenue Growth (YoY) | +73.00% |
| Gross Margin | +57.52% |
| Operating Margin | -20.41% |
| Profit Margin | -13.15% |
| ROE | -5.68% |
| Debt / Equity | 10.67 |
| Current Ratio | 0.69 |
| Total Cash | $164,385 |
| Total Debt | $2.56M |
| Free Cash Flow | $69,885 |
Source: Nexqual, July 25, 2026 at 16:26 UTC.
Financial Health Score (HYEX)
Nexqual rates Healthy Extracts Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 16:26 UTC.
| Growth | Strong — Revenue +73% YoY (latest Q) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Solid — $164K cash vs $3M debt |
| Cash Flow | Mixed — FCF $70K, slim 1.5% margin |
| Efficiency | Critical — ROE -6%, ROA -4.9% |
Ownership (HYEX)
| Insider Ownership | +80.53% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 14.73M |
| Float | 3.29M |
Source: Nexqual, July 25, 2026 at 16:26 UTC.
Leadership (HYEX)
Healthy Extracts Inc. is led by Donald Swanson (age 66), CEO & Chairman, per Nexqual as of July 25, 2026 at 16:26 UTC.
| CEO & Chairman | Donald Swanson (age 66) |
|---|---|
| President, COO, Treasurer & Director | Kevin Pitts (age 65) |
| CFO & Secretary | Robert Madden (age 53) |
| Executive Vice President of Sales & Marketing | J. Scott Landers |
From Healthy Extracts Inc.'s Latest SEC 10-K Filing (filed 2026-04-09)
Key Strengths & Strategy (as disclosed to the SEC)
- Healthy Extracts Inc., through its subsidiaries, engages in acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals in the United States.
- It operates through Corporate and Health Supplements segments.
- The company's proprietary and patented products target categories within the nutraceuticals market, such as heart, brain, and immune health.
- It also provides heart and immune health products, including bergamot-based products in tablet and capsule form; and plant-based health technology neuro-products that enhance brain health comprising memory, cognition, focus, and neuro-energy.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GSAC | GelStat Corp. | USD 0 | ▲ 0% |
| KOAN | Resonate Blends Inc. | USD 0 | ▲ 0% |
| BBBT | BLACK BIRD BIOTECH INC | USD 0 | ▲ 0% |
| AOXG | Aoxing Pharmaceutical Company, | USD 0 | ▲ 0% |
| EMGE | Emergent Health Corp. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 16:26 UTC. This page is informational and not investment advice.